-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Akari Therapeutics Plc quarterly/annual Earnings Per Share, Diluted history and growth rate from 2019 to 2023.
- Akari Therapeutics Plc Earnings Per Share, Diluted for the quarter ending June 30, 2024 was -0.09 USD/shares, a 69% increase year-over-year.
- Akari Therapeutics Plc annual Earnings Per Share, Diluted for 2023 was -0.61 USD/shares, a 17.6% increase from 2022.
- Akari Therapeutics Plc annual Earnings Per Share, Diluted for 2022 was -0.74 USD/shares.
- Akari Therapeutics Plc annual Earnings Per Share, Diluted for 2021 was 0 USD/shares.
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Growth (%)